Bharat Biotech gets DCGI nod for PHASE II trials of COVAXIN
The subject expert committee (SEC) has recommended that the trial will be conducted on 380 participants
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.